We also confirmed the prognostic value of LC3B in lung cancer patients from The Cancer Genome Atlas (TCGA) cohort (expression data are described in http://www.cbioportal.org/public-portal/) [31, 32]. This evidence concerns the gene MAP1LC3B and lung carcinoma.